MediWound Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2011
Net Income	-12.75	-6.72	-19.6	-13.55	-9.2	4.96	Upgrade
Depreciation & Amortization	1.37	1.3	1.27	1.24	1.09	1.15	Upgrade
Share-Based Compensation	1.83	1.94	1.95	1.67	1.32	1.23	Upgrade
Other Operating Activities	-6.17	-6.99	4.5	1.72	-0.11	0.95	Upgrade
Operating Cash Flow	-15.73	-10.47	-11.89	-8.92	-6.9	8.29	Upgrade
Capital Expenditures	-6.22	-6.46	-0.56	-0.49	-0.92	-0.79	Upgrade
Change in Investments	-24.69	-29.8	0	4	18.03	-5.05	Upgrade
Other Investing Activities	2.25	1.95	0.07	0.04	0.27	-1.06	Upgrade
Investing Cash Flow	-28.66	-34.32	-0.48	3.55	17.39	-6.9	Upgrade
Share Issuance / Repurchase	0.25	24.91	38.38	0	0	0	Upgrade
Debt Issued / Paid	-2.1	-1.61	-2.37	-0.69	-0.51	-0.63	Upgrade
Other Financing Activities	-0.19	-0.38	-0.25	-0.36	-0.12	-0.38	Upgrade
Financing Cash Flow	-2.04	22.92	35.76	-1.05	-0.63	-1.01	Upgrade
Exchange Rate Effect	0.09	-0.16	-0.55	0.09	0.27	0.14	Upgrade
Net Cash Flow	-46.33	-22.03	22.85	-6.33	10.13	0.53	Upgrade
Free Cash Flow	-21.94	-16.93	-12.44	-9.41	-7.82	7.5	Upgrade
Free Cash Flow Margin	-110.54%	-90.60%	-46.95%	-39.58%	-35.92%	23.58%	Upgrade
Free Cash Flow Per Share	-2.38	-1.88	-2.49	-2.42	-2.01	1.93	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).